Editorial
Published on 26 Jul 2021
Editorial: Premature Aging and Senescence in Renal Fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.734892
- 3,790 views
- 1 citation
Type at least 3 characters
656 articles
Original Research
Published on 26 Jul 2021
Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.714584
- 4,383 views
- 12 citations
Original Research
Published on 26 Jul 2021
Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.676345
- 11,367 views
- 23 citations
Systematic Review
Published on 20 Jul 2021
The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.665250
- 16,366 views
- 26 citations
Systematic Review
Published on 19 Jul 2021
Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.691878
- 5,797 views
- 12 citations
Original Research
Published on 15 Jul 2021
Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.667644
- 19,320 views
- 98 citations
Systematic Review
Published on 14 Jul 2021
Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.667753
- 27,145 views
- 68 citations
Editorial
Published on 08 Jul 2021
Editorial: Combating Diabetes and Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.716029
- 2,789 views
- 7 citations
Systematic Review
Published on 02 Jul 2021
Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.658079
- 9,471 views
- 17 citations
Brief Research Report
Published on 02 Jul 2021
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.626510
- 5,631 views
- 18 citations
Original Research
Published on 24 Jun 2021
The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.604928
- 5,169 views
- 17 citations
Original Research
Published on 24 Jun 2021
Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.680336
- 5,407 views
- 17 citations
Original Research
Published on 22 Jun 2021
Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.662020
- 13,744 views
- 30 citations
Review
Published on 16 Jun 2021
The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.695237
- 4,509 views
- 11 citations
Opinion
Published on 28 May 2021
Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.692429
- 7,651 views
- 14 citations
Original Research
Published on 28 May 2021
Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.667282
- 4,171 views
- 8 citations